Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.14 Insider Own12.75% Shs Outstand10.54M Perf Week2.74%
Market Cap23.71M Forward P/E56.25 EPS next Y0.04 Insider Trans4.84% Shs Float9.20M Perf Month11.39%
Income-1.44M PEG- EPS next Q-0.01 Inst Own40.30% Short Float0.04% Perf Quarter10.84%
Sales14.06M P/S1.69 EPS this Y76.67% Inst Trans1.04% Short Ratio0.29 Perf Half Y-36.08%
Book/sh0.78 P/B2.90 EPS next Y214.29% ROA-12.87% Short Interest0.00M Perf Year60.71%
Cash/sh0.34 P/C6.53 EPS next 5Y- ROE-16.84% 52W Range1.32 - 4.04 Perf YTD-34.97%
Dividend Est.- P/FCF- EPS past 5Y21.13% ROI-15.16% 52W High-44.35% Beta1.19
Dividend TTM- Quick Ratio2.77 Sales past 5Y24.85% Gross Margin58.86% 52W Low71.04% ATR (14)0.10
Dividend Ex-Date- Current Ratio4.21 EPS Y/Y TTM74.95% Oper. Margin-10.57% RSI (14)58.07 Volatility3.26% 3.71%
Employees31 Debt/Eq0.21 Sales Y/Y TTM21.78% Profit Margin-10.23% Recom1.00 Target Price4.75
Option/ShortNo / Yes LT Debt/Eq0.16 EPS Q/Q45.79% Payout- Rel Volume1.89 Prev Close2.11
Sales Surprise-5.47% EPS Surprise50.00% Sales Q/Q-4.73% EarningsMay 08 Avg Volume13.24K Price2.25
SMA206.32% SMA504.55% SMA200-8.51% Trades Volume25,042 Change6.64%
Date Action Analyst Rating Change Price Target Change
Jan-26-21Initiated B. Riley Securities Buy $12.50
May-09-24 04:15PM
May-02-24 07:30AM
Apr-29-24 09:00AM
Apr-23-24 07:30AM
Mar-08-24 01:01PM
04:15PM Loading…
Mar-07-24 04:15PM
Feb-29-24 04:30PM
Nov-11-23 12:41PM
Nov-08-23 04:15PM
Nov-01-23 07:30AM
Oct-25-23 07:30AM
Sep-19-23 04:30PM
Aug-09-23 04:15PM
Jul-26-23 07:30AM
May-24-23 07:30AM
04:15PM Loading…
May-10-23 04:15PM
May-08-23 07:30AM
Apr-26-23 07:30AM
Apr-04-23 07:30AM
Mar-08-23 04:15PM
Mar-01-23 04:30PM
Feb-22-23 04:30PM
Jan-11-23 07:30AM
Nov-02-22 04:15PM
Oct-19-22 07:30AM
Oct-12-22 07:30AM
Oct-11-22 07:30AM
Sep-28-22 07:30AM
Sep-08-22 04:00PM
Aug-13-22 08:22AM
04:15PM Loading…
Aug-10-22 04:15PM
Jul-27-22 07:30AM
Jul-06-22 07:30AM
May-17-22 07:30AM
May-04-22 04:15PM
Apr-27-22 07:30AM
Apr-26-22 07:30AM
Mar-21-22 07:30AM
Feb-28-22 07:30AM
Feb-23-22 04:15PM
Feb-09-22 07:30AM
Jan-13-22 07:30AM
Jan-11-22 07:30AM
Nov-23-21 04:15PM
Nov-08-21 07:30AM
Nov-04-21 04:15PM
Oct-21-21 07:30AM
Oct-08-21 07:30AM
Oct-05-21 07:30AM
Sep-15-21 09:39AM
Sep-06-21 11:42AM
Sep-01-21 07:30AM
Aug-05-21 04:15PM
Jul-28-21 03:03PM
Jul-12-21 07:30AM
Jul-09-21 04:18PM
Jul-08-21 11:20AM
Jun-29-21 08:50AM
Jun-23-21 09:35AM
May-31-21 08:50AM
May-06-21 04:15PM
Apr-26-21 07:30AM
Apr-09-21 05:29AM
Apr-05-21 07:30AM
Mar-16-21 07:45AM
Mar-10-21 07:30AM
Mar-04-21 02:07AM
Mar-01-21 04:15PM
Feb-22-21 07:30AM
Feb-18-21 07:30AM
Jan-22-21 02:21AM
Jan-12-21 07:30AM
Jan-05-21 10:55AM
Jan-04-21 07:30AM
Nov-29-20 09:33AM
Nov-19-20 06:45AM
Nov-09-20 07:30AM
Nov-05-20 04:27PM
Oct-29-20 07:30AM
Oct-24-20 10:47AM
Oct-16-20 07:30AM
Oct-13-20 07:30AM
Oct-07-20 07:30AM
Oct-06-20 07:30AM
Aug-31-20 05:00PM
Aug-25-20 07:30AM
Aug-14-20 07:30AM
Aug-06-20 01:43PM
Aug-05-20 04:15PM
Jul-29-20 07:30AM
Jul-22-20 07:30AM
Jul-16-20 11:00AM
Jul-14-20 07:30AM
Jul-13-20 07:30AM
Jul-08-20 07:30AM
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amron Arthur HDirectorMay 30 '24Buy2.243,0006,735103,463May 30 04:35 PM
Amron Arthur HDirectorMay 28 '24Buy2.222,0004,441100,463May 30 04:35 PM
Banks Robert R. Jr.President and CEOMay 16 '24Buy2.2450,000112,05070,000May 16 04:49 PM
Amron Arthur HDirectorMar 12 '24Buy2.457,00017,1307,000Mar 14 04:28 PM
Banks Robert R. Jr.President and CEODec 07 '23Buy2.2018,00039,64720,000Dec 11 04:17 PM
Banks Robert R. Jr.President and CEOAug 15 '23Buy1.691,9013,2072,000Aug 15 04:15 PM
Banks Robert R. Jr.President and CEOAug 14 '23Buy1.509914899Aug 15 04:15 PM